Table 2.
Demographic and Baseline Characteristics of Patients From 4 Studies of Duloxetine for the Treatment of Fibromyalgia
| Characteristic | Duloxetine (n = 797) | Placebo (n = 535) | Total (N = 1,332) |
| Age, mean (SD), y | 50.6 (10.7) | 49.6 (11.3) | 50.2 (11.0) |
| Female, n (%) | 754 (94.6) | 508 (95.0) | 1,262 (94.7) |
| Male, n (%)a | 43 (5.4) | 27 (5.1) | 70 (5.3) |
| White, n (%) | 705 (88.5) | 464 (86.7) | 1,169 (87.8) |
| Hispanic, n (%) | 67 (8.4) | 51 (9.5) | 118 (8.9) |
| Black, n (%) | 16 (2.0) | 13 (2.4) | 29 (2.2) |
| Major depressive disorder, n (%) | 203 (25.5) | 147 (27.5) | 350 (26.3) |
a
Percent based on the 3 studies that included male patients.